|
🇬🇧 MHRA publishes guidelines for Nitrosamine Impurities
|
|
4
|
1444
|
August 28, 2023
|
|
Optimized method development strategies for the quantification of small and complex N-nitrosamines impurities
|
|
0
|
479
|
August 25, 2023
|
|
Nitroso-methylphenidate
|
|
4
|
710
|
August 25, 2023
|
|
Q&A revision 17 uploaded on EMA page
|
|
12
|
1552
|
August 25, 2023
|
|
A nitrosamine twist
|
|
0
|
473
|
August 24, 2023
|
|
CPCA - Methyl group bonded to beta carbon (cyclic/acyclic) (activating factor)
|
|
2
|
1310
|
August 23, 2023
|
|
Strategies for Assessing Acceptable Intakes for Novel N-Nitrosamines Derived from Active Pharmaceutical Ingredients
|
|
4
|
677
|
August 23, 2023
|
|
Approaches and Considerations for the Investigation and Synthesis of N‑Nitrosamine Drug Substance-Related Impurities (NDSRIs)
|
|
0
|
700
|
August 23, 2023
|
|
Nitrosaminas: Estrutura química vs Potencial carcinogênico
|
|
3
|
583
|
August 23, 2023
|
|
Potency score for protected hydroxy group
|
|
2
|
462
|
August 22, 2023
|
|
N-Nitroso N-Desmethyl Nefopam
|
|
4
|
970
|
August 18, 2023
|
|
Considerations for high-risk unit operations
|
|
2
|
535
|
August 18, 2023
|
|
IPA-QF Guidance on Nitrosamines Impurities
|
|
0
|
769
|
August 18, 2023
|
|
🤷♂️ FAQ: How do I calculate the CPCA of my Nitrosamine Impurity?
|
|
3
|
4491
|
August 17, 2023
|
|
🗓 Nitrosamines Conversation Event w/ Dr. Raphael Nudelman
|
|
16
|
2719
|
August 17, 2023
|
|
NCD add on for GC
|
|
0
|
351
|
August 16, 2023
|
|
Risk Assessemento of Nitrosamines in soft capsule
|
|
6
|
1353
|
August 16, 2023
|
|
Measuring Nitrites in headspace
|
|
4
|
627
|
August 15, 2023
|
|
Total impurities limit if more than one nitrosamine impurities are observed in product
|
|
4
|
682
|
August 14, 2023
|
|
N-nitroso-hydrochlorothiazide limit
|
|
2
|
606
|
August 14, 2023
|
|
On the Risk of Nitrosamine Contamination during blister packaging
|
|
2
|
1019
|
August 10, 2023
|
|
Testing of APIs for NDSRI
|
|
4
|
1068
|
August 10, 2023
|
|
Nitrosamines in EDQM 2023 Webinar Series
|
|
7
|
1089
|
August 10, 2023
|
|
Common nitrosamine impurity limit calculation when it is contributing from both API as well as excipients
|
|
9
|
1296
|
August 8, 2023
|
|
🇺🇸 FDA Recommended AI Limits for Certain Hypothetical NDSRIs
|
|
0
|
1272
|
August 8, 2023
|
|
Read & Post in your own language -NEW Feature
|
|
4
|
457
|
August 7, 2023
|
|
👨💻 Quantitation of NDMA in Ranitidine DS by LC-MS/MS
|
|
1
|
1491
|
August 7, 2023
|
|
Planilha CPCA na prática
|
|
0
|
469
|
August 6, 2023
|
|
Lhasa Japan Symposium
|
|
0
|
426
|
August 3, 2023
|
|
NDMA in Drug Product
|
|
2
|
542
|
August 3, 2023
|